Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

16 avr. 2026 21h11 HE | Source: Robbins LLP

UHG Class Action Reminder - Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the United Homes Group, Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that United Homes Group, Inc. (UHG) Misled Investors Regarding the Forthcoming Sale of the Company
14 avr. 2026 18h41 HE | Source: Robbins LLP

UHG Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against United Homes Group, Inc.

Robbins LLP is Investigating Allegations that United Homes Group, Inc. (UHG) Misled Investors Regarding the Forthcoming Sale of the Company
25 sept. 2025 07h30 HE | Source: Plus Therapeutics Inc.

Plus Therapeutics Announces National Coverage Agreement with UnitedHealthcare Insurance Company for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

HOUSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), announced today that it has signed...